DOI QR코드

DOI QR Code

Immunomodulatory effects of β-1,3/1,6-glucan and lactic acid bacteria in LP-BM5 murine leukemia viruses-induced murine acquired immune deficiency syndrome

면역결핍 모델에서 β-1,3/1,6-glucan과 유산균을 이용한 in vivo 면역 활성 조절 효과

  • Kim, Min-Soo (Microbial Biotechnology Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB)) ;
  • Kim, JoongSu (Microbial Biotechnology Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB)) ;
  • Ryu, Min Jung (Department of Cosmetology science, Nambu University) ;
  • Kim, Ki hong (Jeonnam Institute for Regional Program Evaluation) ;
  • Hwang, Kwontack (Department of Food and Nutrition, Nambu University)
  • 김민수 (한국생명공학연구원 미생물기능연구센터) ;
  • 김중수 (한국생명공학연구원 미생물기능연구센터) ;
  • 류민정 (남부대학교 향장미용학과) ;
  • 김기홍 ((재)전남지역사업평가단) ;
  • 황권택 (남부대학교 식품영양학과)
  • Received : 2017.09.18
  • Accepted : 2017.12.20
  • Published : 2017.12.30

Abstract

In this study, ${\beta}$-1,3/1,6-glucan, lactic acid bacteria, and ${\beta}$-1,3/1,6-glucan+lactic acid bacteria were tested for 10 weeks using an immunodeficient animal model infected with LP-BM5 murine AIDS virus On the immune activity. Cytokines production, plasma immunoglobulin concentration, T cell and B cell proliferation were measured. As a result, the T cell proliferative capacity which was weakened by immunization with LP-BM5 murine AIDS virus increased significantly T cell proliferative capacity compared with the red ginseng control group. B cell proliferative capacity was significantly higher than the infected control group. Increased B cell proliferation was reduced. In the cytokine production, IL-2, IL-12 and IL-15 in the Th1-type cytokine increased the secretion of IL-2, IL-12 and IL-15 compared to the infected control. The proliferative capacity of the treated group was higher than that of the mixed treatment group. TNF-${\alpha}$ was significantly decreased compared with the infected control group. The IL-4, IL-6 and IL-10 levels were significantly inhibited in the infected control group and the Th1/Th2 type cytokine expression was regulated by immunohistochemistry. IgE, IgA, and IgG levels were significantly lower in the immunoglobulin secretion assay than in the control. As a result, the immunomodulatory effect of ${\beta}$-1,3/1,6-glucan+lactic acid bacteria was confirmed by mixing with LP-BM5 murine AIDS virus-infected immunodeficient animal model.

본 연구에서는 LP-BM5 murine AIDS virus에 감염된 면역 결핍동물 모델을 이용하여 실험기간 10주 동안 ${\beta}$-1,3/1,6-glucan, 유산균 및 ${\beta}$-1,3/1,6-glucan+유산균의 식이가 면역활성에 미치는 영향을 조사하였다. 그 결과 LP-BM5 murine AIDS virus에 감염으로 면역능이 떨어진 T세포 증식능은 홍삼대조군과 비교하여도 유의적으로 감소된 T 세포증식능을 증가시키는 것으로 나타났고, B 세포 증식능은 감염 대조군에 비하여 유의적으로 증가된 B 세포 증식능을 감소되었다. cytokine 생성능에서는 Th1 type cytokine중에서 IL-2, IL-12, IL-15는 감염대조군에 비하여 분비량을 증가시키는 것을 확인할 수 있었고, IFN-${\gamma}$는 유산균과 ${\beta}$-1,3/1,6-glucan을 각각 처리군이 혼합처리군보다 증식능이 증가하였다. TNF-${\alpha}$는 감염대조군에 비하여 유의적으로 감소하였다. Th2 cytokine 들의 분비량 측정에서 IL-4, IL-6, IL-10 측정 결과 감염대조군에서 유의적으로 억제되어 Th1/Th2 type cytokine 발현을 조절하여 면역항상성을 유지하는 것으로 보였다. 면역글로블린 분비량측정에서 IgE, IgA, IgG 모두 감염대조군에 비하여 유의적으로 떨어지는 것으로 나타났다. 이로서LP-BM5 murine AIDS virus에 감염된 면역 결핍동물 모델에 ${\beta}$-1,3/1,6-glucan+유산균군을 혼합처리로 면역조절의 효능이 있음을 확인할 수 있었다.

Keywords

References

  1. Tomasi TB Jr, Tan EM, Solomon A, Prendergast RA (1965) Characteristics of an immune system common to certain external secretions. J Exp Med, 121, 101-124 https://doi.org/10.1084/jem.121.1.101
  2. Gonzalez-Rey E, Chorny A, Delgado M (2007) Regulation of immune tolerance by anti-inflammatory neuropeptides. Nat Rev Immunol, 7, 52-63 https://doi.org/10.1038/nri1984
  3. Kim JS (2001) Mechanism of aging and prevention. Immune Network, 1, 104-108 https://doi.org/10.4110/in.2001.1.2.104
  4. KHSA (2016) Health functional food market trends and consumer survey. Korea Health Supplements Association. Seongnam, Korea, p 142-144
  5. McIntosh M, Stone BA, Stanisich VA (2005) Curdlan and other bacterial (1$\rightarrow$ 3)-${\beta}$-D-glucans. Appl Microbiol Biotechnol, 68, 163-173 https://doi.org/10.1007/s00253-005-1959-5
  6. Cui SW, Wang Q (2009) Cell wall polysaccharides in cereals: chemical structures and functional properties. Struct Chem, 20, 291-297 https://doi.org/10.1007/s11224-009-9441-0
  7. Matse AM, Knott ER, Teunissen PGM, Bartels PV (2000) Effects of high isostatic pressure on mushrooms. J Food Eng, 45, 11-6 https://doi.org/10.1016/S0260-8774(00)00035-2
  8. Kimura Y, Sumiyoshi M, Suzuki T, Sakanaka, M (2006) Antitumor and antimetastatic activity of a novel water-soluble low molecular weight ${\beta}$-1, 3-D-glucan (branch ${\beta}$-1, 6) isolated from Aureobasidium pullulans 1A1 strain black yeast. Anticancer Res, 26, 4131-4141
  9. Brown GD, Gordon S (2005) Immune recognition of fungal ${\beta}$ glucans. Cell Microbiol, 7, 471-479 https://doi.org/10.1111/j.1462-5822.2005.00505.x
  10. Brown GD (2006) Dectin-1: a signalling non-TLR pattern-recognition receptor. Nat Rev Immunol, 6, 33-43 https://doi.org/10.1038/nri1745
  11. Lee DH, Kim HW (2014) Innate immunity induced by fungal ${\beta}$-glucans via dectin-1 signaling pathway. Int J Med Mushrooms, 16, 1-16 https://doi.org/10.1615/IntJMedMushr.v16.i1.10
  12. Brown GD, Taylor PR, Reid DM, Willment JA, Williams, DL, Martinez-Pomares L, Wong SYC, Gordon S (2002) Dectin-1 is a major ${\beta}$-glucan receptor on macrophages. J Exp Med, 196, 407-412 https://doi.org/10.1084/jem.20020470
  13. Furrie E (2005) Probiotics and allergy. Proc Nutr Soc, 64, 465-469 https://doi.org/10.1079/PNS2005466
  14. Park HS, Lee SH, Uhm TB (1998) Selection of microorganisms for probiotics and their characterization. J Korean Soc Food Sci Nutr, 27, 433-440
  15. Rather IA, Bajpai VK, Kumar S, Lim JH, Paek WK, Park YH (2016) Probiotics and Atopic Dermatitis: An Overview. Front Microbiol. 7, 1-7
  16. Laiho K, Hoppu U, Ouwehand AC, Salminen S, Isolauri E (2002) Probiotics: on-going research on atopic individuals. Br J Nutr, 88, S19-S27 https://doi.org/10.1079/BJN2002626
  17. Kim HJ, Kim YJ, Lee SH, Yu J, Jeong SK, Hong SJ (2014) Effects of Lactobacillus rhamnosus on allergic march model by suppressing Th2, Th17, and TSLP responses via $CD4^{(+)}CD25^{(+)}Foxp3^{(+)}$ Tregs. Clin immunol, 153, 178-186 https://doi.org/10.1016/j.clim.2014.04.008
  18. Yoon JY, Hwang KT (2016) An in vitro study of immune activity by ${\beta}$-1,3/1,6-glucan isolated from Aureobasidium pullulans. Korean J Food Preserv, 23, 906-912
  19. Lee SJ, Ahn KH, Park CS, Yoon BD, Kim MS (2009) Analysis of ${\beta}$-(1$\rightarrow$3)(1$\rightarrow$6)-glucan produced by Aureobasidium pullulans IMS-822. Korean J Microbiol, 45, 63-68
  20. W Oboshi, M Amakawa, R Kato (2014) Effects of ${\beta}$-glucan and lactic acid bacteria on gut immune system. Jap J Med Technol, 63, 673-679
  21. Iida R, Saito K, Yamada K, Basile AS, Sekikawa K, Takemura M, Fujii H, Wada H, Seishima M, Nabeshima T (2000) Suppression of neurocognitive damage in LP-BM5-infected mice with a targeted deletion of the TNF-${\alpha}$ gene. FASEB J, 14, 1023-1031 https://doi.org/10.1096/fasebj.14.7.1023
  22. Liang B, Wang JY, Watson RR (1996) Murine AIDS, a key to understanding retrovirus-induced immunodeficiency. Viral Immunol, 9, 225-239 https://doi.org/10.1089/vim.1996.9.225
  23. Odeleye OE, Eskelson CD, Watson RR (1992) Changes in hepatic lipid composition after infection by LP-BM5 murine leukemia virus causing murine AIDS. Life Sci, 51, 129-134 https://doi.org/10.1016/0024-3205(92)90006-B
  24. Dimitrov DS, Norwood D, Stantchev TS, Feng Y, Xiao X, Broder CC (1999) A mechanism of resistance to HIV-1 entry: inefficient interactions of CXCR4 with CD4 and gp120 in macrophages. Virology, 259, 1-6 https://doi.org/10.1006/viro.1999.9747
  25. Moir S, Buckner CM, Ho J, Wang W, Chen J, Waldner AJ, Posada JG, Kardava L, O'Shea MA, Kottilil S, Chun TW, Proschan MA, Fauci AS (2010) B cells in early and chronic HIV infection: evidence for preservation of immune function associated with early initiation of antiretroviral therapy. Blood, 116, 5571-5579 https://doi.org/10.1182/blood-2010-05-285528
  26. Gougeon ML, Lecoeur H, Dulioust A, Enouf MG, Crouvoiser M, Goujard C, Debord T, Montagnier L (1996) Programmed cell death in peripheral lymphocytes from HIV-infected persons: increased susceptibility to apoptosis of CD4 and CD8 T cells correlates with lymphocyte activation and with disease progression. J Immunol, 156, 3509-3520
  27. Morris L, Binley JM, Clas BA, Bonhoeffer S, Astill TP, Kost R, Hurley A, Cao Y, Markowitz M, Ho DD, Moore JP (1998) HIV-1 antigen-specific and -nonspecific B cell responses are sensitive to combination antiretroviral therapy. J Exp Med, 188, 233-245 https://doi.org/10.1084/jem.188.2.233
  28. Meyaard L, Schuitemaker H, Miedema F (1993) T-cell dysfunction in HIV infection: anergy due to defective antigen- presenting cell function? Immunol Today, 14, 161-164 https://doi.org/10.1016/0167-5699(93)90279-T
  29. Zimmerli SC, Harari A, Cellerai C, Vallelian F, Bart PA, Pantaleo G (2005) HIV-1-specific IFN-${\gamma}$/IL-2-secreting CD8 T cells support CD4-independent proliferation of HIV-1-specific CD8 T cells. PNAS, 102, 7239-7244 https://doi.org/10.1073/pnas.0502393102
  30. Moir S, Malaspina A, Li Y, Chun TW, Lowe T, Adelsberger J, Baseler M, Ehler LA, Liu S, Davey RT Jr, Mican JA, Fauci AS (2000) B cells of HIV-1-infected patients bind virions through CD21-complement interactions and transmit infectious virus to activated T cells. J Exp Med, 192, 637-645 https://doi.org/10.1084/jem.192.5.637